These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Thrombin generation is not increased in the blood of hemophilia B patients after the infusion of a purified factor IX concentrate. Mannucci PM, Bauer KA, Gringeri A, Barzegar S, Bottasso B, Simoni L, Rosenberg RD. Blood; 1990 Dec 15; 76(12):2540-5. PubMed ID: 2265248 [Abstract] [Full Text] [Related]
4. Thrombogenicity of a factor IX concentrate quantitated in a canine model. MacGregor IR, Ferguson JF, Dawes J, McLaughlin L, Prowse CV. Blood Coagul Fibrinolysis; 1990 Dec 15; 1(1):23-30. PubMed ID: 2102787 [Abstract] [Full Text] [Related]
5. No activation of the common pathway of the coagulation cascade after a highly purified factor IX concentrate. Mannucci PM, Bauer KA, Gringeri A, Barzegar S, Santagostino E, Tradati FC, Rosenberg RD. Br J Haematol; 1991 Dec 15; 79(4):606-11. PubMed ID: 1772782 [Abstract] [Full Text] [Related]
6. In vitro spontaneous thrombin generation in human factor-IX concentrates. Sas G, Owens RE, Smith JK, Middleton S, Cash JD. Br J Haematol; 1975 Sep 15; 31(1):25-35. PubMed ID: 1212434 [Abstract] [Full Text] [Related]
7. Reduced coagulation activation following infusion of a highly purified factor IX concentrate compared to a prothrombin complex concentrate. Hampton KK, Preston FE, Lowe GD, Walker ID, Sampson B. Br J Haematol; 1993 Jun 15; 84(2):279-84. PubMed ID: 8398831 [Abstract] [Full Text] [Related]
9. Potential thrombogenicity of heat-treated prothrombin complex concentrates in Haemophilia B. Hampton KK, Makris M, Kitchen S, Preston FE. Blood Coagul Fibrinolysis; 1991 Oct 15; 2(5):637-41. PubMed ID: 1782333 [Abstract] [Full Text] [Related]
10. Assessment of thrombogenicity of prothrombin complex concentrates in a porcine model. Harrison J, Abildgaard C, Lazerson J, Culbertson R, Anderson G. Thromb Res; 1985 Apr 15; 38(2):173-88. PubMed ID: 4002204 [Abstract] [Full Text] [Related]
11. Immunoaffinity purification of factor IX from commercial concentrates and infusion studies in animals. Smith KJ. Blood; 1988 Oct 15; 72(4):1269-77. PubMed ID: 3262386 [Abstract] [Full Text] [Related]
12. Activated clotting factors in factor IX concentrates. Hultin MB. Blood; 1979 Nov 15; 54(5):1028-38. PubMed ID: 497395 [Abstract] [Full Text] [Related]
13. Various prothrombin complex concentrates and their effect on coagulation and fibrinolysis in vivo. Hedner U, Nilsson IM, Bergentz SE. Thromb Haemost; 1976 Apr 30; 35(2):386-95. PubMed ID: 989639 [Abstract] [Full Text] [Related]
14. Human factor IX in animals: kinetics from isolated, radiolabelled protein and platelet destruction following crude concentrate infusions. Thompson AR, Forrey AW, Gentry PA, Smith KJ, Harker LA. Br J Haematol; 1980 Jun 30; 45(2):329-42. PubMed ID: 7437328 [Abstract] [Full Text] [Related]
16. A comparison of the in vitro and in vivo thrombogenic activity of factor IX concentrates using stasis (Wessler) and non-stasis rabbit models. Prowse CV, Williams AE. Thromb Haemost; 1980 Oct 31; 44(2):81-6. PubMed ID: 6779401 [Abstract] [Full Text] [Related]
18. A novel rat model of thrombogenicity: its use in evaluation of prothrombin complex concentrates and high purity factor IX concentrates. McLaughlin LF, Drummond O, MacGregor IR. Thromb Haemost; 1992 Nov 10; 68(5):511-5. PubMed ID: 1455396 [Abstract] [Full Text] [Related]